Nagase Brothers Inc. FY2026 Q3 Earnings Report

Quick View

Executive Summary

Q3 results achieved double-digit growth with Revenue of ¥477.2B (YoY +¥82.3B +20.9%), Operating Income of ¥49.0B (YoY +¥10.8B +28.4%), Ordinary Income of ¥48.5B (YoY +¥18.3B +60.8%), and Net Income of ¥32.9B (YoY +¥16.3B +98.2%). Operating margin improved to 10.3%, up 0.6pt from 9.7% a year ago, delivering both top-line growth and enhanced profitability. Net Income nearly doubled YoY, and Comprehensive Income expanded significantly to ¥75.2B, driven by growth in Other Comprehensive Income including valuation differences on investment securities. Full-year guidance calls for Revenue of ¥647.6B (+17.2%), Operating Income of ¥65.3B (+34.1%), and Net Income of ¥38.2B, with Q3 progress at 73.7% for Revenue and 75.1% for Operating Income, indicating steady progress.

Key Financial Indicators

[Profitability] ROE 9.1% (DuPont: Net Profit Margin 6.9% × Total Asset Turnover 0.498 × Financial Leverage 2.66), Operating Margin 10.3% (+0.6pt from 9.7% a year ago), and Net Profit Margin 6.9% indicate improving profitability. Interest Coverage 17.7x, Interest Burden Ratio 1.034, implying ample capacity to service interest. [Cash Quality] Cash and Deposits ¥182.5B (YoY +¥39.0B), covering Short-term Liabilities of ¥215.5B at 0.85x. Short-term Borrowings ¥17.9B (YoY +¥10.0B +126.3%), indicating increased short-term funding. Inventories ¥5.0B (YoY +¥1.7B +51.8%), reflecting higher inventory levels. [Investment Efficiency] Total Asset Turnover 0.498x. Investment Securities increased to ¥254.2B (YoY +¥60.6B +31.3%), with valuation gains contributing to Other Comprehensive Income. [Financial Soundness] Equity Ratio 37.6% (+3.0pt from 34.6% a year ago), Current Ratio 114.0%, Quick Ratio 111.7%, indicating secured short-term liquidity. Interest-bearing Debt ¥229.2B, Debt-to-Equity Ratio 1.66x, Debt-to-Capital Ratio 38.9%, representing an appropriate level of financial leverage.

Cash Flow Analysis

Cash and Deposits increased by ¥39.0B YoY to ¥182.5B, supported by higher operating profits and stronger cash generation. Working capital stands at ¥30.2B, maintaining efficiency, but Inventories surged by ¥1.7B to ¥5.0B (+51.8%), which could impact cash efficiency depending on inventory management trends. Short-term Borrowings expanded by ¥10.0B to ¥17.9B (+126.3%), necessitating monitoring of maturity mismatches. Investment Securities rose by ¥60.6B to ¥254.2B (+31.3%), reflecting progressing capital allocation via investing activities. Accounts Receivable at ¥39.4B remain restrained relative to sales growth, suggesting healthy collections. Cash and Deposits cover Short-term Liabilities at 0.85x and cover Short-term Borrowings alone at 10.2x, indicating ample liquidity; however, given increased funding needs from investment expansion and inventory buildup, ongoing tracking of Operating Cash Flow and Free Cash Flow is important.

Quality of Earnings

Ordinary Income was ¥48.5B versus Operating Income of ¥49.0B, implying a minor net non-operating decrease of approximately ¥0.5B. Operating Income is the primary earnings driver, indicating a sustainable earnings structure. Other Comprehensive Income expanded significantly, with ¥42.3B of the ¥75.2B in Comprehensive Income attributable to items such as valuation differences on Investment Securities, reflecting mark-to-market gains. The 10.3% Operating Margin improved from last year due to fixed cost absorption accompanying sales growth and operating leverage, indicating an uptrend in recurring earning power. However, part of Comprehensive Income depends on fluctuations in investment valuations; alignment with pure operating cash generation should be verified. Non-operating items show a small interest burden, with ample capacity to service interest supporting earnings stability. The effective tax rate is approximately 35.1%, somewhat elevated, but consistent with the increase in pre-tax profit.

Risk Factors

• Short-term Borrowings Increase Risk: Short-term Borrowings expanded to ¥17.9B, up +126.3% YoY, posing risks of maturity mismatch and rising funding costs. While Cash and Deposits are sufficient, attention is needed to volatility in short-term funding.
• Investment Securities Valuation Risk: With Investment Securities at ¥254.2B (+31.3%), market value fluctuations could significantly affect Other Comprehensive Income and future P&L. In deteriorating market conditions, there is a risk of recognizing valuation losses.
• Inventory Management Risk: Inventories surged to ¥5.0B, up +51.8% YoY, posing risks of inventory write-downs or markdowns due to shifts in the sales cycle or supply-demand mismatches.
• Tax Burden Risk: The effective tax rate is 35.1%, somewhat high; changes in tax laws or reversal of deferred tax assets could pressure Net Income.
• Market Demand Risk: Demand fluctuations in core segments (High School Business, Sports Business, etc.) could slow revenue growth. Achieving the full-year forecast Operating Margin of 10.1% requires maintaining operating efficiency in the second half.

Industry Benchmark (Reference, Our Research)

[Position within Industry] (Reference Information, Our Research) Profitability: Operating Margin of 10.3% exceeds the industry median of 8.2% (IQR: 5.210.9%), placing the company at an upper-tier level within the industry. Net Profit Margin of 6.9% exceeds the industry median of 5.7% (IQR: 3.19.1%), indicating solid profit efficiency. ROE 9.1% is slightly below the industry median of 9.7% (IQR: 3.915.0%) but remains mid-tier. ROA is estimated to be mid-range compared with the industry median of 4.7% (IQR: 2.48.1%). Soundness: Equity Ratio of 37.6% is below the industry median of 49.0% (IQR: 38.866.3%), making it somewhat low within the industry. Current Ratio of 114.0% is well below the industry median of 206%, indicating relatively restrained liquidity for the sector profile. Efficiency: Revenue growth of 20.9% significantly exceeds the industry median of 9.5% (IQR: 2.715.2%), positioning the company as a high-growth name. Total Asset Turnover of 0.498x is estimated to be mid-tier within the industry, reflecting standard asset efficiency. Sector: Healthcare (44 companies), Comparison Base: 2025 Q3 results, Source: Our compilation

Key Takeaways from Results

First, with Revenue growth of +20.9% and Operating Income up +28.4%, operating leverage is clearly at work, and progress toward achieving the full-year Operating Income target of ¥65.3B is steady. Second, Investment Securities expanded by +31.3% to ¥254.2B, and Other Comprehensive Income, including valuation differences, accounts for 56% of the ¥75.2B in Comprehensive Income, indicating that mark-to-market movements in the investment portfolio will be a driver of future earnings volatility. Third, the +126.3% increase in Short-term Borrowings and +51.8% increase in Inventories suggest structural changes in funding and inventory management; verifying the sustainability of cash generation through actual OCF and FCF results is important. The dividend forecast of ¥150 reflects a shareholder return stance, but given the Payout Ratio relative to the full-year forecast Net Income of ¥38.2B will be at a high level, checking alignment with Free Cash Flow is key to assessing dividend sustainability.

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings report data. It does not constitute a solicitation to invest in any specific security. The industry benchmarks are reference information compiled by us based on publicly available earnings data. Investment decisions are your own responsibility; please consult a professional as necessary.